For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Third Harmonic Bio Inc (NASDAQ: THRD) closed the day trading at $5.12 up 10.34% from the previous closing price of $4.64. In other words, the price has increased by $10.34 from its previous closing price. On the day, 0.55 million shares were traded. THRD stock price reached its highest trading level at $5.285 during the session, while it also had its lowest trading level at $4.63.
Ratios:
For a better understanding of THRD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 42.50 and its Current Ratio is at 42.50. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on August 09, 2024, Upgraded its rating to Overweight and sets its target price to $20 from $12 previously.
On June 18, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $23.
On June 07, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $18.Raymond James initiated its Outperform rating on June 07, 2024, with a $18 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 08 ’24 when Conner Edward R. sold 2,117 shares for $15.00 per share. The transaction valued at 31,755 led to the insider holds 0 shares of the business.
BVF PARTNERS L P/IL sold 1,000,000 shares of THRD for $14,300,000 on Oct 29 ’24. The See Explanation of Responses now owns 176,692 shares after completing the transaction at $14.30 per share. On Oct 28 ’24, another insider, Conner Edward R., who serves as the Chief Medical Officer of the company, sold 2,673 shares for $15.00 each. As a result, the insider received 40,095 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, THRD now has a Market Capitalization of 230699008 and an Enterprise Value of -83618960.
Stock Price History:
The Beta on a monthly basis for THRD is 2.70, which has changed by -0.5196687 over the last 52 weeks, in comparison to a change of 0.20587826 over the same period for the S&P500. Over the past 52 weeks, THRD has reached a high of $16.94, while it has fallen to a 52-week low of $4.62. The 50-Day Moving Average of the stock is -44.47%, while the 200-Day Moving Average is calculated to be -56.78%.
Shares Statistics:
Over the past 3-months, THRD traded about 245.60K shares per day on average, while over the past 10 days, THRD traded about 218120 shares per day. A total of 44.73M shares are outstanding, with a floating share count of 16.76M. Insiders hold about 62.80% of the company’s shares, while institutions hold 40.02% stake in the company. Shares short for THRD as of 1736899200 were 3521408 with a Short Ratio of 14.34, compared to 1734048000 on 3351019. Therefore, it implies a Short% of Shares Outstanding of 3521408 and a Short% of Float of 15.619999000000002.
